KRAS mutation: Comparison of testing methods and tissue sampling techniques in colon cancer

Wilbur A. Franklin, Jerry Haney, Michio Sugita, Lynne Bemis, Antonio Jimeno, Wells A. Messersmith

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon carcinoma: 1) high resolution melting, 2) the amplification refractory mutation system using a bifunctional self-probing primer (ARMS/Scorpion, ARMS/S), and 3) direct sequencing. We also evaluated the effects of the methods of sectioning and coring of paraffin blocks to obtain tumor DNA on assay sensitivity and specificity. The most sensitive and specific combination of block sampling and mutational analysis was ARMS/S performed on DNA derived from 1-mm paraffin cores. This combination of tissue sampling and testing method detected KRAS mutations in 46% of colon tumors. Four samples were positive by ARMS/S, but initially negative by direct sequencing. Cloned DNA samples were retested by direct sequencing, and in all four cases KRAS mutations were identified in the DNA. In six cases, high resolution melting abnormalities could not be confirmed as specific mutations either by ARMS/S or direct sequencing. We conclude that coring of the paraffin blocks and testing by ARMS/S is a sensitive, specific, and efficient method for KRAS testing.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalJournal of Molecular Diagnostics
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Scorpions
Colonic Neoplasms
Mutation
Paraffin
Colon
DNA
Freezing
Carcinoma
Neoplasms
Epidermal Growth Factor Receptor
Sensitivity and Specificity
Antibodies

Cite this

KRAS mutation : Comparison of testing methods and tissue sampling techniques in colon cancer. / Franklin, Wilbur A.; Haney, Jerry; Sugita, Michio; Bemis, Lynne; Jimeno, Antonio; Messersmith, Wells A.

In: Journal of Molecular Diagnostics, Vol. 12, No. 1, 01.01.2010, p. 43-50.

Research output: Contribution to journalArticle

Franklin, Wilbur A. ; Haney, Jerry ; Sugita, Michio ; Bemis, Lynne ; Jimeno, Antonio ; Messersmith, Wells A. / KRAS mutation : Comparison of testing methods and tissue sampling techniques in colon cancer. In: Journal of Molecular Diagnostics. 2010 ; Vol. 12, No. 1. pp. 43-50.
@article{e86b7ca8736247ea8dbfbeaa65581f50,
title = "KRAS mutation: Comparison of testing methods and tissue sampling techniques in colon cancer",
abstract = "Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon carcinoma: 1) high resolution melting, 2) the amplification refractory mutation system using a bifunctional self-probing primer (ARMS/Scorpion, ARMS/S), and 3) direct sequencing. We also evaluated the effects of the methods of sectioning and coring of paraffin blocks to obtain tumor DNA on assay sensitivity and specificity. The most sensitive and specific combination of block sampling and mutational analysis was ARMS/S performed on DNA derived from 1-mm paraffin cores. This combination of tissue sampling and testing method detected KRAS mutations in 46{\%} of colon tumors. Four samples were positive by ARMS/S, but initially negative by direct sequencing. Cloned DNA samples were retested by direct sequencing, and in all four cases KRAS mutations were identified in the DNA. In six cases, high resolution melting abnormalities could not be confirmed as specific mutations either by ARMS/S or direct sequencing. We conclude that coring of the paraffin blocks and testing by ARMS/S is a sensitive, specific, and efficient method for KRAS testing.",
author = "Franklin, {Wilbur A.} and Jerry Haney and Michio Sugita and Lynne Bemis and Antonio Jimeno and Messersmith, {Wells A.}",
year = "2010",
month = "1",
day = "1",
doi = "10.2353/jmoldx.2010.080131",
language = "English (US)",
volume = "12",
pages = "43--50",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "1",

}

TY - JOUR

T1 - KRAS mutation

T2 - Comparison of testing methods and tissue sampling techniques in colon cancer

AU - Franklin, Wilbur A.

AU - Haney, Jerry

AU - Sugita, Michio

AU - Bemis, Lynne

AU - Jimeno, Antonio

AU - Messersmith, Wells A.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon carcinoma: 1) high resolution melting, 2) the amplification refractory mutation system using a bifunctional self-probing primer (ARMS/Scorpion, ARMS/S), and 3) direct sequencing. We also evaluated the effects of the methods of sectioning and coring of paraffin blocks to obtain tumor DNA on assay sensitivity and specificity. The most sensitive and specific combination of block sampling and mutational analysis was ARMS/S performed on DNA derived from 1-mm paraffin cores. This combination of tissue sampling and testing method detected KRAS mutations in 46% of colon tumors. Four samples were positive by ARMS/S, but initially negative by direct sequencing. Cloned DNA samples were retested by direct sequencing, and in all four cases KRAS mutations were identified in the DNA. In six cases, high resolution melting abnormalities could not be confirmed as specific mutations either by ARMS/S or direct sequencing. We conclude that coring of the paraffin blocks and testing by ARMS/S is a sensitive, specific, and efficient method for KRAS testing.

AB - Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon carcinoma: 1) high resolution melting, 2) the amplification refractory mutation system using a bifunctional self-probing primer (ARMS/Scorpion, ARMS/S), and 3) direct sequencing. We also evaluated the effects of the methods of sectioning and coring of paraffin blocks to obtain tumor DNA on assay sensitivity and specificity. The most sensitive and specific combination of block sampling and mutational analysis was ARMS/S performed on DNA derived from 1-mm paraffin cores. This combination of tissue sampling and testing method detected KRAS mutations in 46% of colon tumors. Four samples were positive by ARMS/S, but initially negative by direct sequencing. Cloned DNA samples were retested by direct sequencing, and in all four cases KRAS mutations were identified in the DNA. In six cases, high resolution melting abnormalities could not be confirmed as specific mutations either by ARMS/S or direct sequencing. We conclude that coring of the paraffin blocks and testing by ARMS/S is a sensitive, specific, and efficient method for KRAS testing.

UR - http://www.scopus.com/inward/record.url?scp=77349103908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77349103908&partnerID=8YFLogxK

U2 - 10.2353/jmoldx.2010.080131

DO - 10.2353/jmoldx.2010.080131

M3 - Article

C2 - 20007845

AN - SCOPUS:77349103908

VL - 12

SP - 43

EP - 50

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 1

ER -